跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
NMPA
/
Pramipexole Dihydrochloride Sustained Release Tablets
Approved
化学药品
Pramipexole Dihydrochloride Sustained Release Tablets
MacLeods Pharmaceuticals Ltd.
🇨🇳 National Medical Products Administration
Approval Date
Dec 5, 2023
Approval ID
8VgmmYp3UPI
Company
MacLeods Pharmaceuticals Ltd.
Type
化学药品
Approval Details
Approval Id
8VgmmYp3UPI
Approval Number
国药准字HJ20230137
Generic Name
盐酸普拉克索缓释片
Generic Name En
Pramipexole Dihydrochloride Sustained Release Tablets
Drug Type
化学药品
Dosage Form
片剂
Strength
1.5mg（按C₁₀H₁₇N₃S•2HCl•H₂O计）
Reg Date
2023-12-05
Expired Date
2028-12-04
Company Name
MacLeods Pharmaceuticals Ltd.
Production Company Name
MacLeods Pharmaceuticals Ltd.
Company Detail Path
/organization/macleods-pharmaceuticals-ltd
Production Company Detail Path
/organization/macleods-pharmaceuticals-ltd
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Dec 5, 2023
Approval ID
8VgmmYp3UPI
Type
化学药品
Back to NMPA Approvals
盐酸普拉克索缓释片 - NMPA Drug Approval Details
